In addition, further studies are still required to study whether miR‐195 and LINC00461 expressions are associated with the presence of KRAS and EGFR in lung adenocarcinoma and to better elucidate the modulatory role of KRAS and EGFR in NSCLC. The gene discussed is KRAS; the disease is lung adenocarcinoma.